Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
Oumayma Mnafe, Clinical Hematology Resident at Faculty of Medicine, Pharmacy and Dental Medicine of Fez, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cureus Journal of Medical Science, adding:
“Pleased to share our latest publication about Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma.
A Moroccan Single-Center Retrospective Study.”
Title: Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma: A Moroccan Single-Center Retrospective Study
Authors: Oumayma Mnafe, Asmae Jamlaoui, Hicham Eddou
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!